ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Liver"

  • 2022 American Transplant Congress

    Liver Transplantation for Metabolic Liver Disease

    J. Wothe, H. Bhatt, D. Vock, S. Schwarzenberg, V. Kirchner, S. Chinnakotla

    University of Minnesota Medical School, Minneapolis, MN

    *Purpose: Liver transplantation (LT) was initially developed as a therapy for liver diseases known to be associated with a high risk of near-term mortality. As…
  • 2022 American Transplant Congress

    Patient-Reported Physical Function Correlates with Liver Frailty Index and 4-Meter Gait Speed in Patients with Cirrhosis

    A. J. Thuluvath, J. Peipert, K. Belfanti, S. Morrissey, O. Siddiqui, J. Levitsky, Z. Dietch, A. Flores, D. P. Ladner

    Northwestern University Feinberg School of Medicine, Chicago, IL

    *Purpose: Frailty is highly prevalent in patients with end-stage liver disease and strongly predicts waitlist and post-transplant mortality. The Liver Frailty Index (LFI) and 4-meter…
  • 2022 American Transplant Congress

    Defatting of Steatotic Liver Grafts by Normothermic Ex Vivo Liver Machine Perfusion with 2,4 Dinitrophenol

    J. M. Gassner1, J. Michelotto1, S. Moosburner1, F. Strobl1, A. L. Birkenfeld2, A. Kurzbach2, G. Shulman3, X. Zhang3, M. Selzner4, Y. Noguchi4, J. Pratschke1, I. M. Sauer1, N. Raschzok1

    1Department of Surgery, Experimental Surgery, Charité – Universitätsmedizin Berlin, Berlin, Germany, 2Division of Endocrinology, Diabetology and Nephrology, Department of Internal Medicine, Internal, University Hospital Tübingen, Tübingen, Germany, 3Departments of Internal Medicine and Cellular & Molecular Physiology, Yale Diabetes Research Center, Yale School of Medicine, New Haven, CT, 4Multi Organ Transplant Program, Ajmera Family Transplant Center, Toronto General Hospital, University of Toronto, Toronto, ON, Canada

    *Purpose: The purpose of the study is to demonstrate that steatotic liver grafts can be defatted by normothermic ex vivo liver machine perfusion (NEVLP) with…
  • 2022 American Transplant Congress

    Equivalence of Pediatric Paper and Electronic-Based Patient-Reported Outcome Measures: Findings from a Systematic Review

    S. Kortbeek1, A. Pawaria2, V. L. Ng1

    1Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, The Hospital for Sick Children, Toronto, ON, Canada, 2Pediatric Hepatology, Gastroenterology and Liver Transplant, Global Hospitals, Mumbai, India

    *Purpose: Integration of patient reported outcome measures (PROMs) in routine clinical care reduces utilisation of health care services and improves patient outcomes. Electronic versions of…
  • 2022 American Transplant Congress

    Sars-CoV-2 Antibody Response Before and After Third Dose of Homologous mRNA Vaccine in Liver Transplant Recipients

    A. T. Strauss1, A. Chang1, J. Alejo1, T. Chiang1, L. Zeiser1, N. Fortune1, B. Boyarsky1, R. Avery2, A. A. Tobian1, M. Levan1, D. S. Warren1, A. Massie3, J. Garonzik-Wang1, D. Segev1, W. Werbel1

    1Johns Hopkins University, Baltimore, MD, 2Johns Hopkins, Baltimore, MD, 3Johns Hopkins School of Medicine, Baltimore, MD

    *Purpose: Liver transplant (LT) recipients have a decreased response to 2 doses of SARS-CoV-2 vaccine compared to the general population, so we aimed to understand…
  • 2022 American Transplant Congress

    Practices and Perceptions of Living Donor Liver Transplant, Non-Directed Donation, and Liver Paired Exchange: A National Survey

    A. Kaplan1, R. Rosenblatt1, W. Jackson2, R. Brown1, B. Samstein1

    1New York Presbyterian Weill Cornell, New York, NY, 2University of Colorado Denver, Denver, CO

    *Purpose: Living donor liver transplant (LDLT) remains under-utilized in the United States. The aim of this study, therefore, was to assess the perceptions and practices…
  • 2022 American Transplant Congress

    Higher Baseline Serum Creatinine Levels AreAssociated with an Increased Incidence of Renal Replacement Therapy in Patients with Hepatorenal Syndrome Type 1 on the Liver Transplant Waitlist

    S. N. Sclair1, A. Befeler2, K. Jamil3

    1Hepatology, University Hospitals Cleveland Medical Center & Case Western Reserve University, Cleveland, OH, 2Gastroenterology, Hepatology, Transplant Hepatology, Saint Louis University School of Medicine, St Louis, MO, 3Hepatology, Mallinckrodt Pharmaceuticals, Clinton, NJ

    *Purpose: Pretransplant and posttransplant renal replacement therapy (RRT) is associated with increased morbidity and mortality in liver transplant recipients, including those with Hepatorenal syndrome type…
  • 2022 American Transplant Congress

    Socioeconomic Factors Influence Likelihood of Directed Living Donor Transplant Among Children with End-Stage Renal or Liver Disease

    D. Yoeli, S. Mathai, C. O'Neill, E. Lamberty, J. Kaar, C. Mata, A. Feldman, M. Bock, W. Jackson, M. Adams

    University of Colorado Anschutz Medical, Aurora, CO

    *Purpose: Previous studies have demonstrated that children with public insurance are less likely to receive a transplant from a directed living donor. Type of insurance…
  • 2022 American Transplant Congress

    Evaluation of Different Initial Tacrolimus Dosing Regimens in Pediatric Post-Liver Transplantation

    A. F. Alghanem1, A. Alsmari1, H. Joharji2

    1Pharmaceutical Care, King Abdulaziz Medical City, Riyadh, Saudi Arabia, 2Pharmaceutical Care, King Faisal Specialized Hospital and Research Center, Riyadh, Saudi Arabia

    *Purpose: Tacrolimus is an immunosuppressant used in post-liver transplantation, has wide pharmacokinetic variability, particularly in pediatric patients. Therefore, this study aimed to evaluate different weight-based…
  • 2022 American Transplant Congress

    A Single Center Analysis of Organ Offers and Workload for Liver and Kidney Allocation

    V. Reddy, T. Ma, R. Ruiz, H. Fernandez, J. Bayer, N. Onaca, E. Martinez, A. Gupta, S. Lee, G. J. McKenna, G. Testa, A. Wall

    Baylor University Medical Center, Dallas, TX

    *Purpose: UNOS/OPTN transitioned to Acuity Circles allocation for kidneys and livers which has increased the complexity of the network of organ procurement organizations (OPOs) and…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 50
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences